ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastrointestinal Motility Drugs Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-32E17924
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gastrointestinal Motility Drugs Market Research Report 2024
BUY CHAPTERS

Global Gastrointestinal Motility Drugs Market Research Report 2024

Code: QYRE-Auto-32E17924
Report
August 2024
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Hanmi Pharm.Co.,Ltd.
Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
Vendors
Jiangxi Huiren Pharmaceutical Co., Ltd.
Janssen Pharmaceutica
Pfizer Inc
Abbott
Sumitomo Pharma Co. Ltd.
Taj Pharmaceuticals Limited
Midas Pharma GmbH
Ani Pharmaceuticals Inc.
Jiangsu Jibei Pharmaceutical Co., Ltd.
Shandong Xinhua Pharmaceutical Co Ltd
Yabao Pharmaceutical Group Co. Ltd
Guangdong Annuo Pharmaceutical Co., Ltd.
Lunan Beite Pharmaceutical Co., Ltd.
Jiangsu Hausen Pharmaceutical Group Co., Ltd.
Shandong FANGMING Pharmaceutical Group Co., Ltd.
Shijiazhuang Siyao Co., Ltd.
China Resources Double-Crane Pharmaceutical Co., Ltd.
Zhuhai Rundu Pharmaceutical Co.,Ltd
Chenxin Pharmaceutical Co., Ltd.
Hainan Asia Pharmaceutical Co., Ltd.
Sichuan Zilinggong Pharmaceutical Co., Ltd.
Disa Pharmaceutical Group Co., Ltd.

Gastrointestinal Motility Drugs Market

The global Gastrointestinal Motility Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Gastrointestinal Motility Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gastrointestinal Motility Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gastrointestinal Motility Drugs include Janssen Pharmaceutica, Pfizer, Abbott, Sumitomo Pharma Co., Ltd., Hanmi Pharm. Co., Ltd., Taj Pharmaceuticals Limited, Midas Pharma GmbH, ANI Pharmaceuticals, Inc., Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd., Jiangxi Huiren Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Motility Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Motility Drugs.
The Gastrointestinal Motility Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Gastrointestinal Motility Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Motility Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gastrointestinal Motility Drugs Market Report

Report Metric Details
Report Name Gastrointestinal Motility Drugs Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Janssen Pharmaceutica, Pfizer, Abbott, Sumitomo Pharma Co., Ltd., Hanmi Pharm. Co., Ltd., Taj Pharmaceuticals Limited, Midas Pharma GmbH, ANI Pharmaceuticals, Inc., Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd., Jiangxi Huiren Pharmaceutical Co., Ltd., Hainan Asia Pharmaceutical Co., Ltd., Jiangsu Jibei Pharmaceutical Co., Ltd., Shandong Xinhua Pharmaceutical Co., Ltd., Sichuan Zilinggong Pharmaceutical Co., Ltd., Yabao Pharmaceutical Group Co., Ltd., Guangdong Annuo Pharmaceutical Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., Jiangsu Hausen Pharmaceutical Group Co., Ltd., Shandong Fangming Pharmaceutical Group Co., Ltd., Shijiazhuang Siyao Co., Ltd., China Resources Double Crane Pharmaceutical Co., Ltd., Zhuhai Rundu Pharmaceutical Co., Ltd., Disa Pharmaceutical Group Co., Ltd., Chenxin Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gastrointestinal Motility Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gastrointestinal Motility Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Gastrointestinal Motility Drugs Market report?

Ans: The main players in the Gastrointestinal Motility Drugs Market are Janssen Pharmaceutica, Pfizer, Abbott, Sumitomo Pharma Co., Ltd., Hanmi Pharm. Co., Ltd., Taj Pharmaceuticals Limited, Midas Pharma GmbH, ANI Pharmaceuticals, Inc., Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd., Jiangxi Huiren Pharmaceutical Co., Ltd., Hainan Asia Pharmaceutical Co., Ltd., Jiangsu Jibei Pharmaceutical Co., Ltd., Shandong Xinhua Pharmaceutical Co., Ltd., Sichuan Zilinggong Pharmaceutical Co., Ltd., Yabao Pharmaceutical Group Co., Ltd., Guangdong Annuo Pharmaceutical Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., Jiangsu Hausen Pharmaceutical Group Co., Ltd., Shandong Fangming Pharmaceutical Group Co., Ltd., Shijiazhuang Siyao Co., Ltd., China Resources Double Crane Pharmaceutical Co., Ltd., Zhuhai Rundu Pharmaceutical Co., Ltd., Disa Pharmaceutical Group Co., Ltd., Chenxin Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Gastrointestinal Motility Drugs Market report?

Ans: The Applications covered in the Gastrointestinal Motility Drugs Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Gastrointestinal Motility Drugs Market report?

Ans: The Types covered in the Gastrointestinal Motility Drugs Market report are Domperidone, Metoclopramide, Mosapride, Minaprocaine Bromide, Itopride

Recommended Reports

Gastrointestinal Drugs

Bowel Disease Therapies

GI Disease Therapeutics

1 Gastrointestinal Motility Drugs Market Overview
1.1 Product Definition
1.2 Gastrointestinal Motility Drugs by Type
1.2.1 Global Gastrointestinal Motility Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Domperidone
1.2.3 Metoclopramide
1.2.4 Mosapride
1.2.5 Minaprocaine Bromide
1.2.6 Itopride
1.3 Gastrointestinal Motility Drugs by Application
1.3.1 Global Gastrointestinal Motility Drugs Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Gastrointestinal Motility Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastrointestinal Motility Drugs Revenue 2019-2030
1.4.2 Global Gastrointestinal Motility Drugs Sales 2019-2030
1.4.3 Global Gastrointestinal Motility Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gastrointestinal Motility Drugs Market Competition by Manufacturers
2.1 Global Gastrointestinal Motility Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gastrointestinal Motility Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gastrointestinal Motility Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Gastrointestinal Motility Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastrointestinal Motility Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastrointestinal Motility Drugs, Product Type & Application
2.7 Global Key Manufacturers of Gastrointestinal Motility Drugs, Date of Enter into This Industry
2.8 Global Gastrointestinal Motility Drugs Market Competitive Situation and Trends
2.8.1 Global Gastrointestinal Motility Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gastrointestinal Motility Drugs Players Market Share by Revenue
2.8.3 Global Gastrointestinal Motility Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gastrointestinal Motility Drugs Market Scenario by Region
3.1 Global Gastrointestinal Motility Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gastrointestinal Motility Drugs Sales by Region: 2019-2030
3.2.1 Global Gastrointestinal Motility Drugs Sales by Region: 2019-2024
3.2.2 Global Gastrointestinal Motility Drugs Sales by Region: 2025-2030
3.3 Global Gastrointestinal Motility Drugs Revenue by Region: 2019-2030
3.3.1 Global Gastrointestinal Motility Drugs Revenue by Region: 2019-2024
3.3.2 Global Gastrointestinal Motility Drugs Revenue by Region: 2025-2030
3.4 North America Gastrointestinal Motility Drugs Market Facts & Figures by Country
3.4.1 North America Gastrointestinal Motility Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gastrointestinal Motility Drugs Sales by Country (2019-2030)
3.4.3 North America Gastrointestinal Motility Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gastrointestinal Motility Drugs Market Facts & Figures by Country
3.5.1 Europe Gastrointestinal Motility Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gastrointestinal Motility Drugs Sales by Country (2019-2030)
3.5.3 Europe Gastrointestinal Motility Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastrointestinal Motility Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Gastrointestinal Motility Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gastrointestinal Motility Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Gastrointestinal Motility Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gastrointestinal Motility Drugs Market Facts & Figures by Country
3.7.1 Latin America Gastrointestinal Motility Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gastrointestinal Motility Drugs Sales by Country (2019-2030)
3.7.3 Latin America Gastrointestinal Motility Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Gastrointestinal Motility Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastrointestinal Motility Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gastrointestinal Motility Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gastrointestinal Motility Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastrointestinal Motility Drugs Sales by Type (2019-2030)
4.1.1 Global Gastrointestinal Motility Drugs Sales by Type (2019-2024)
4.1.2 Global Gastrointestinal Motility Drugs Sales by Type (2025-2030)
4.1.3 Global Gastrointestinal Motility Drugs Sales Market Share by Type (2019-2030)
4.2 Global Gastrointestinal Motility Drugs Revenue by Type (2019-2030)
4.2.1 Global Gastrointestinal Motility Drugs Revenue by Type (2019-2024)
4.2.2 Global Gastrointestinal Motility Drugs Revenue by Type (2025-2030)
4.2.3 Global Gastrointestinal Motility Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Gastrointestinal Motility Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gastrointestinal Motility Drugs Sales by Application (2019-2030)
5.1.1 Global Gastrointestinal Motility Drugs Sales by Application (2019-2024)
5.1.2 Global Gastrointestinal Motility Drugs Sales by Application (2025-2030)
5.1.3 Global Gastrointestinal Motility Drugs Sales Market Share by Application (2019-2030)
5.2 Global Gastrointestinal Motility Drugs Revenue by Application (2019-2030)
5.2.1 Global Gastrointestinal Motility Drugs Revenue by Application (2019-2024)
5.2.2 Global Gastrointestinal Motility Drugs Revenue by Application (2025-2030)
5.2.3 Global Gastrointestinal Motility Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Gastrointestinal Motility Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Janssen Pharmaceutica
6.1.1 Janssen Pharmaceutica Company Information
6.1.2 Janssen Pharmaceutica Description and Business Overview
6.1.3 Janssen Pharmaceutica Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Janssen Pharmaceutica Gastrointestinal Motility Drugs Product Portfolio
6.1.5 Janssen Pharmaceutica Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Gastrointestinal Motility Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Gastrointestinal Motility Drugs Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Sumitomo Pharma Co., Ltd.
6.4.1 Sumitomo Pharma Co., Ltd. Company Information
6.4.2 Sumitomo Pharma Co., Ltd. Description and Business Overview
6.4.3 Sumitomo Pharma Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sumitomo Pharma Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.4.5 Sumitomo Pharma Co., Ltd. Recent Developments/Updates
6.5 Hanmi Pharm. Co., Ltd.
6.5.1 Hanmi Pharm. Co., Ltd. Company Information
6.5.2 Hanmi Pharm. Co., Ltd. Description and Business Overview
6.5.3 Hanmi Pharm. Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hanmi Pharm. Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.5.5 Hanmi Pharm. Co., Ltd. Recent Developments/Updates
6.6 Taj Pharmaceuticals Limited
6.6.1 Taj Pharmaceuticals Limited Company Information
6.6.2 Taj Pharmaceuticals Limited Description and Business Overview
6.6.3 Taj Pharmaceuticals Limited Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Taj Pharmaceuticals Limited Gastrointestinal Motility Drugs Product Portfolio
6.6.5 Taj Pharmaceuticals Limited Recent Developments/Updates
6.7 Midas Pharma GmbH
6.7.1 Midas Pharma GmbH Company Information
6.7.2 Midas Pharma GmbH Description and Business Overview
6.7.3 Midas Pharma GmbH Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Midas Pharma GmbH Gastrointestinal Motility Drugs Product Portfolio
6.7.5 Midas Pharma GmbH Recent Developments/Updates
6.8 ANI Pharmaceuticals, Inc.
6.8.1 ANI Pharmaceuticals, Inc. Company Information
6.8.2 ANI Pharmaceuticals, Inc. Description and Business Overview
6.8.3 ANI Pharmaceuticals, Inc. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ANI Pharmaceuticals, Inc. Gastrointestinal Motility Drugs Product Portfolio
6.8.5 ANI Pharmaceuticals, Inc. Recent Developments/Updates
6.9 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
6.9.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Company Information
6.9.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.9.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Jiangxi Huiren Pharmaceutical Co., Ltd.
6.10.1 Jiangxi Huiren Pharmaceutical Co., Ltd. Company Information
6.10.2 Jiangxi Huiren Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Jiangxi Huiren Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jiangxi Huiren Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.10.5 Jiangxi Huiren Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Hainan Asia Pharmaceutical Co., Ltd.
6.11.1 Hainan Asia Pharmaceutical Co., Ltd. Company Information
6.11.2 Hainan Asia Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Hainan Asia Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hainan Asia Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.11.5 Hainan Asia Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Jiangsu Jibei Pharmaceutical Co., Ltd.
6.12.1 Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information
6.12.2 Jiangsu Jibei Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Jiangsu Jibei Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jiangsu Jibei Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.12.5 Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Shandong Xinhua Pharmaceutical Co., Ltd.
6.13.1 Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
6.13.2 Shandong Xinhua Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Shandong Xinhua Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shandong Xinhua Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.13.5 Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Sichuan Zilinggong Pharmaceutical Co., Ltd.
6.14.1 Sichuan Zilinggong Pharmaceutical Co., Ltd. Company Information
6.14.2 Sichuan Zilinggong Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Sichuan Zilinggong Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sichuan Zilinggong Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.14.5 Sichuan Zilinggong Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Yabao Pharmaceutical Group Co., Ltd.
6.15.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
6.15.2 Yabao Pharmaceutical Group Co., Ltd. Description and Business Overview
6.15.3 Yabao Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Yabao Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.15.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.16 Guangdong Annuo Pharmaceutical Co., Ltd.
6.16.1 Guangdong Annuo Pharmaceutical Co., Ltd. Company Information
6.16.2 Guangdong Annuo Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Guangdong Annuo Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Guangdong Annuo Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.16.5 Guangdong Annuo Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Lunan Beite Pharmaceutical Co., Ltd.
6.17.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
6.17.2 Lunan Beite Pharmaceutical Co., Ltd. Description and Business Overview
6.17.3 Lunan Beite Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Lunan Beite Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.17.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments/Updates
6.18 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
6.18.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
6.18.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Description and Business Overview
6.18.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.18.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.19 Shandong Fangming Pharmaceutical Group Co., Ltd.
6.19.1 Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information
6.19.2 Shandong Fangming Pharmaceutical Group Co., Ltd. Description and Business Overview
6.19.3 Shandong Fangming Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Shandong Fangming Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.19.5 Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.20 Shijiazhuang Siyao Co., Ltd.
6.20.1 Shijiazhuang Siyao Co., Ltd. Company Information
6.20.2 Shijiazhuang Siyao Co., Ltd. Description and Business Overview
6.20.3 Shijiazhuang Siyao Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Shijiazhuang Siyao Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.20.5 Shijiazhuang Siyao Co., Ltd. Recent Developments/Updates
6.21 China Resources Double Crane Pharmaceutical Co., Ltd.
6.21.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
6.21.2 China Resources Double Crane Pharmaceutical Co., Ltd. Description and Business Overview
6.21.3 China Resources Double Crane Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.21.4 China Resources Double Crane Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.21.5 China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
6.22 Zhuhai Rundu Pharmaceutical Co., Ltd.
6.22.1 Zhuhai Rundu Pharmaceutical Co., Ltd. Company Information
6.22.2 Zhuhai Rundu Pharmaceutical Co., Ltd. Description and Business Overview
6.22.3 Zhuhai Rundu Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Zhuhai Rundu Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.22.5 Zhuhai Rundu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.23 Disa Pharmaceutical Group Co., Ltd.
6.23.1 Disa Pharmaceutical Group Co., Ltd. Company Information
6.23.2 Disa Pharmaceutical Group Co., Ltd. Description and Business Overview
6.23.3 Disa Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Disa Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.23.5 Disa Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.24 Chenxin Pharmaceutical Co., Ltd.
6.24.1 Chenxin Pharmaceutical Co., Ltd. Company Information
6.24.2 Chenxin Pharmaceutical Co., Ltd. Description and Business Overview
6.24.3 Chenxin Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Chenxin Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
6.24.5 Chenxin Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastrointestinal Motility Drugs Industry Chain Analysis
7.2 Gastrointestinal Motility Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastrointestinal Motility Drugs Production Mode & Process
7.4 Gastrointestinal Motility Drugs Sales and Marketing
7.4.1 Gastrointestinal Motility Drugs Sales Channels
7.4.2 Gastrointestinal Motility Drugs Distributors
7.5 Gastrointestinal Motility Drugs Customers
8 Gastrointestinal Motility Drugs Market Dynamics
8.1 Gastrointestinal Motility Drugs Industry Trends
8.2 Gastrointestinal Motility Drugs Market Drivers
8.3 Gastrointestinal Motility Drugs Market Challenges
8.4 Gastrointestinal Motility Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Hanmi Pharm.Co.,Ltd.
Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
Vendors
Jiangxi Huiren Pharmaceutical Co., Ltd.
Janssen Pharmaceutica
Pfizer Inc
Abbott
Sumitomo Pharma Co. Ltd.
Taj Pharmaceuticals Limited
Midas Pharma GmbH
Ani Pharmaceuticals Inc.
Jiangsu Jibei Pharmaceutical Co., Ltd.
Shandong Xinhua Pharmaceutical Co Ltd
Yabao Pharmaceutical Group Co. Ltd
Guangdong Annuo Pharmaceutical Co., Ltd.
Lunan Beite Pharmaceutical Co., Ltd.
Jiangsu Hausen Pharmaceutical Group Co., Ltd.
Shandong FANGMING Pharmaceutical Group Co., Ltd.
Shijiazhuang Siyao Co., Ltd.
China Resources Double-Crane Pharmaceutical Co., Ltd.
Zhuhai Rundu Pharmaceutical Co.,Ltd
Chenxin Pharmaceutical Co., Ltd.
Hainan Asia Pharmaceutical Co., Ltd.
Sichuan Zilinggong Pharmaceutical Co., Ltd.
Disa Pharmaceutical Group Co., Ltd.
List of Tables
 Table 1. Global Gastrointestinal Motility Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Gastrointestinal Motility Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Gastrointestinal Motility Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Gastrointestinal Motility Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Gastrointestinal Motility Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Gastrointestinal Motility Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Gastrointestinal Motility Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Gastrointestinal Motility Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Gastrointestinal Motility Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gastrointestinal Motility Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gastrointestinal Motility Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Gastrointestinal Motility Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gastrointestinal Motility Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Motility Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gastrointestinal Motility Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Gastrointestinal Motility Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Gastrointestinal Motility Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Gastrointestinal Motility Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Gastrointestinal Motility Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Gastrointestinal Motility Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Gastrointestinal Motility Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Gastrointestinal Motility Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Gastrointestinal Motility Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Gastrointestinal Motility Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Gastrointestinal Motility Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Gastrointestinal Motility Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Gastrointestinal Motility Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Gastrointestinal Motility Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Gastrointestinal Motility Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Gastrointestinal Motility Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Gastrointestinal Motility Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Gastrointestinal Motility Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Gastrointestinal Motility Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Gastrointestinal Motility Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Gastrointestinal Motility Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Gastrointestinal Motility Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Gastrointestinal Motility Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Gastrointestinal Motility Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Gastrointestinal Motility Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Gastrointestinal Motility Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Gastrointestinal Motility Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Gastrointestinal Motility Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Gastrointestinal Motility Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Gastrointestinal Motility Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Gastrointestinal Motility Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Gastrointestinal Motility Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Gastrointestinal Motility Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Gastrointestinal Motility Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Gastrointestinal Motility Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global Gastrointestinal Motility Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global Gastrointestinal Motility Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Gastrointestinal Motility Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Gastrointestinal Motility Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Gastrointestinal Motility Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Gastrointestinal Motility Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Gastrointestinal Motility Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Gastrointestinal Motility Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Gastrointestinal Motility Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Gastrointestinal Motility Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global Gastrointestinal Motility Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global Gastrointestinal Motility Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Gastrointestinal Motility Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Gastrointestinal Motility Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Gastrointestinal Motility Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Gastrointestinal Motility Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Gastrointestinal Motility Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Gastrointestinal Motility Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Gastrointestinal Motility Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Janssen Pharmaceutica Company Information
 Table 71. Janssen Pharmaceutica Description and Business Overview
 Table 72. Janssen Pharmaceutica Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Janssen Pharmaceutica Gastrointestinal Motility Drugs Product
 Table 74. Janssen Pharmaceutica Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Pfizer Gastrointestinal Motility Drugs Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Abbott Company Information
 Table 81. Abbott Description and Business Overview
 Table 82. Abbott Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Abbott Gastrointestinal Motility Drugs Product
 Table 84. Abbott Recent Developments/Updates
 Table 85. Sumitomo Pharma Co., Ltd. Company Information
 Table 86. Sumitomo Pharma Co., Ltd. Description and Business Overview
 Table 87. Sumitomo Pharma Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Sumitomo Pharma Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 89. Sumitomo Pharma Co., Ltd. Recent Developments/Updates
 Table 90. Hanmi Pharm. Co., Ltd. Company Information
 Table 91. Hanmi Pharm. Co., Ltd. Description and Business Overview
 Table 92. Hanmi Pharm. Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Hanmi Pharm. Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 94. Hanmi Pharm. Co., Ltd. Recent Developments/Updates
 Table 95. Taj Pharmaceuticals Limited Company Information
 Table 96. Taj Pharmaceuticals Limited Description and Business Overview
 Table 97. Taj Pharmaceuticals Limited Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Taj Pharmaceuticals Limited Gastrointestinal Motility Drugs Product
 Table 99. Taj Pharmaceuticals Limited Recent Developments/Updates
 Table 100. Midas Pharma GmbH Company Information
 Table 101. Midas Pharma GmbH Description and Business Overview
 Table 102. Midas Pharma GmbH Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Midas Pharma GmbH Gastrointestinal Motility Drugs Product
 Table 104. Midas Pharma GmbH Recent Developments/Updates
 Table 105. ANI Pharmaceuticals, Inc. Company Information
 Table 106. ANI Pharmaceuticals, Inc. Description and Business Overview
 Table 107. ANI Pharmaceuticals, Inc. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. ANI Pharmaceuticals, Inc. Gastrointestinal Motility Drugs Product
 Table 109. ANI Pharmaceuticals, Inc. Recent Developments/Updates
 Table 110. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Company Information
 Table 111. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 112. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 114. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 115. Jiangxi Huiren Pharmaceutical Co., Ltd. Company Information
 Table 116. Jiangxi Huiren Pharmaceutical Co., Ltd. Description and Business Overview
 Table 117. Jiangxi Huiren Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Jiangxi Huiren Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 119. Jiangxi Huiren Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 120. Hainan Asia Pharmaceutical Co., Ltd. Company Information
 Table 121. Hainan Asia Pharmaceutical Co., Ltd. Description and Business Overview
 Table 122. Hainan Asia Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Hainan Asia Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 124. Hainan Asia Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 125. Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information
 Table 126. Jiangsu Jibei Pharmaceutical Co., Ltd. Description and Business Overview
 Table 127. Jiangsu Jibei Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Jiangsu Jibei Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 129. Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
 Table 131. Shandong Xinhua Pharmaceutical Co., Ltd. Description and Business Overview
 Table 132. Shandong Xinhua Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Shandong Xinhua Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 134. Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 135. Sichuan Zilinggong Pharmaceutical Co., Ltd. Company Information
 Table 136. Sichuan Zilinggong Pharmaceutical Co., Ltd. Description and Business Overview
 Table 137. Sichuan Zilinggong Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Sichuan Zilinggong Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 139. Sichuan Zilinggong Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 140. Yabao Pharmaceutical Group Co., Ltd. Company Information
 Table 141. Yabao Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 142. Yabao Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Yabao Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 144. Yabao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 145. Guangdong Annuo Pharmaceutical Co., Ltd. Company Information
 Table 146. Guangdong Annuo Pharmaceutical Co., Ltd. Description and Business Overview
 Table 147. Guangdong Annuo Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Guangdong Annuo Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 149. Guangdong Annuo Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 150. Lunan Beite Pharmaceutical Co., Ltd. Company Information
 Table 151. Lunan Beite Pharmaceutical Co., Ltd. Description and Business Overview
 Table 152. Lunan Beite Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. Lunan Beite Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 154. Lunan Beite Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 155. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
 Table 156. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 157. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 159. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 160. Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information
 Table 161. Shandong Fangming Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 162. Shandong Fangming Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. Shandong Fangming Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 164. Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 165. Shijiazhuang Siyao Co., Ltd. Company Information
 Table 166. Shijiazhuang Siyao Co., Ltd. Description and Business Overview
 Table 167. Shijiazhuang Siyao Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 168. Shijiazhuang Siyao Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 169. Shijiazhuang Siyao Co., Ltd. Recent Developments/Updates
 Table 170. China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
 Table 171. China Resources Double Crane Pharmaceutical Co., Ltd. Description and Business Overview
 Table 172. China Resources Double Crane Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 173. China Resources Double Crane Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 174. China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 175. Zhuhai Rundu Pharmaceutical Co., Ltd. Company Information
 Table 176. Zhuhai Rundu Pharmaceutical Co., Ltd. Description and Business Overview
 Table 177. Zhuhai Rundu Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 178. Zhuhai Rundu Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 179. Zhuhai Rundu Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 180. Disa Pharmaceutical Group Co., Ltd. Company Information
 Table 181. Disa Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 182. Disa Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 183. Disa Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 184. Disa Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 185. Chenxin Pharmaceutical Co., Ltd. Company Information
 Table 186. Chenxin Pharmaceutical Co., Ltd. Description and Business Overview
 Table 187. Chenxin Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 188. Chenxin Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product
 Table 189. Chenxin Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 190. Key Raw Materials Lists
 Table 191. Raw Materials Key Suppliers Lists
 Table 192. Gastrointestinal Motility Drugs Distributors List
 Table 193. Gastrointestinal Motility Drugs Customers List
 Table 194. Gastrointestinal Motility Drugs Market Trends
 Table 195. Gastrointestinal Motility Drugs Market Drivers
 Table 196. Gastrointestinal Motility Drugs Market Challenges
 Table 197. Gastrointestinal Motility Drugs Market Restraints
 Table 198. Research Programs/Design for This Report
 Table 199. Key Data Information from Secondary Sources
 Table 200. Key Data Information from Primary Sources
 Table 201. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gastrointestinal Motility Drugs
 Figure 2. Global Gastrointestinal Motility Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Gastrointestinal Motility Drugs Market Share by Type: 2023 & 2030
 Figure 4. Domperidone Product Picture
 Figure 5. Metoclopramide Product Picture
 Figure 6. Mosapride Product Picture
 Figure 7. Minaprocaine Bromide Product Picture
 Figure 8. Itopride Product Picture
 Figure 9. Global Gastrointestinal Motility Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 10. Global Gastrointestinal Motility Drugs Market Share by Application: 2023 & 2030
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Other
 Figure 14. Global Gastrointestinal Motility Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Gastrointestinal Motility Drugs Market Size (2019-2030) & (US$ Million)
 Figure 16. Global Gastrointestinal Motility Drugs Sales (2019-2030) & (K Units)
 Figure 17. Global Gastrointestinal Motility Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 18. Gastrointestinal Motility Drugs Report Years Considered
 Figure 19. Gastrointestinal Motility Drugs Sales Share by Manufacturers in 2023
 Figure 20. Global Gastrointestinal Motility Drugs Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest Gastrointestinal Motility Drugs Players: Market Share by Revenue in Gastrointestinal Motility Drugs in 2023
 Figure 22. Gastrointestinal Motility Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global Gastrointestinal Motility Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America Gastrointestinal Motility Drugs Sales Market Share by Country (2019-2030)
 Figure 25. North America Gastrointestinal Motility Drugs Revenue Market Share by Country (2019-2030)
 Figure 26. United States Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe Gastrointestinal Motility Drugs Sales Market Share by Country (2019-2030)
 Figure 29. Europe Gastrointestinal Motility Drugs Revenue Market Share by Country (2019-2030)
 Figure 30. Germany Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific Gastrointestinal Motility Drugs Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific Gastrointestinal Motility Drugs Revenue Market Share by Region (2019-2030)
 Figure 37. China Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America Gastrointestinal Motility Drugs Sales Market Share by Country (2019-2030)
 Figure 45. Mexico Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa Gastrointestinal Motility Drugs Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa Gastrointestinal Motility Drugs Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE Gastrointestinal Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of Gastrointestinal Motility Drugs by Type (2019-2030)
 Figure 55. Global Revenue Market Share of Gastrointestinal Motility Drugs by Type (2019-2030)
 Figure 56. Global Gastrointestinal Motility Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 57. Global Sales Market Share of Gastrointestinal Motility Drugs by Application (2019-2030)
 Figure 58. Global Revenue Market Share of Gastrointestinal Motility Drugs by Application (2019-2030)
 Figure 59. Global Gastrointestinal Motility Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 60. Gastrointestinal Motility Drugs Value Chain
 Figure 61. Gastrointestinal Motility Drugs Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Gastric Motility Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal Device Market Research Report 2025
Global Digestive System Drugs Market Research Report 2024
Global Pediatric Gastrointestinal Drugs Market Research Report 2025
Global Gastrointestinal GI Devices Market Research Report 2025
Global Gastrointestinal Manometry Devices Market Research Report 2024
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal Forcep Market Research Report 2024
Global Medication For Gastrointestinal Bleeding Market Research Report 2024
Global Intestinal Anti infective Drugs Market Research Report 2024
Gastrointestinal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Irritable Bowel Syndrome Drug Market Research Report 2024
Digestive Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal Suturing Device Market Research Report 2024
Global Constipation Treatment Drug Market Research Report 2025
Global Gastrointestinal AI assisted Diagnosis Market Research Report 2024
Global Gastrointestinal Stent Market Research Report 2025
Global Pediatric Digestive Drugs Market Research Report 2025
Global Gastrointestinal Rare Diseases Treatment Market Research Report 2025
Global Intestinal Cannulation Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions